Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
693.99
241.74
194.02
175.99
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
693.99
241.74
194.02
175.99
0.00
0.00
0.00
Raw Material Cost
148.91
137.41
115.58
53.19
33.85
13.35
11.03
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
176.17
196.11
206.42
145.25
102.28
103.63
33.36
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.76
13.46
16.52
15.89
13.29
4.48
1.78
Selling and Distribution Expenses
80.89
87.67
100.90
93.10
87.88
133.11
30.63
Other Expenses
16.77
16.44
25.74
36.95
22.28
6.75
3.15
Total Expenditure (Excl Depreciation)
584.48
599.02
696.82
676.89
460.10
322.08
108.34
Operating Profit (PBDIT) excl Other Income
109.5
-357.29999999999995
-502.8
-500.90000000000003
-460.09999999999997
-322.1
-108.3
Other Income
81.60
138.03
145.29
6.49
-14.91
38.68
-16.84
Operating Profit (PBDIT)
274.63
-142.87
-293.33
-444.88
-441.15
-270.05
-114.15
Interest
10.76
13.46
16.52
15.89
13.29
4.48
1.78
Exceptional Items
0.00
0.00
-4.75
13.25
7.62
-656.37
-113.05
Gross Profit (PBDT)
545.08
104.33
78.44
122.80
-33.85
-13.35
-11.03
Depreciation
83.52
76.38
64.18
49.54
33.85
13.35
11.03
Profit Before Tax
180.35
-232.70
-378.78
-497.05
-480.68
-944.26
-240.01
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
180.35
-232.70
-378.78
-497.05
-480.68
-944.26
-177.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
180.35
-232.70
-378.78
-497.05
-480.68
-944.26
-177.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-62.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
180.35
-232.70
-378.78
-497.05
-480.68
-944.26
-240.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,949.51
1,841.00
1,748.86
2,287.86
2,695.06
2,713.63
-304.51
Earnings per share (EPS)
0.18
-0.24
-0.4
-0.53
-0.52
-1.05
-0.2
Diluted Earnings per share
0.18
-0.24
-0.4
-0.53
-0.52
-1.05
-0.2
Operating Profit Margin (Excl OI)
15.78%
-147.79%
-259.15%
-284.63%
0.0%
0.0%
0.0%
Gross Profit Margin
38.02%
-64.67%
-162.15%
-254.29%
0.0%
0.0%
0.0%
PAT Margin
25.99%
-96.26%
-195.22%
-282.44%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 187.13% vs 24.59% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 177.52% vs 38.57% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 168.71% vs 35.96% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -20.00% vs -18.18% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Alphamab Oncology With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
693.99
1,312.15
-618.16
-47.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
693.99
1,312.15
-618.16
-47.11%
Raw Material Cost
148.91
316.53
-167.62
-52.96%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
176.17
0.00
176.17
Power Cost
0
0
0.00
Manufacturing Expenses
10.76
48.43
-37.67
-77.78%
Selling and Distribution Expenses
80.89
831.47
-750.58
-90.27%
Other Expenses
16.77
65.48
-48.71
-74.39%
Total Expenditure (Excl Depreciation)
584.48
1,851.22
-1,266.74
-68.43%
Operating Profit (PBDIT) excl Other Income
109.52
-539.07
648.59
120.32%
Other Income
81.60
50.61
30.99
61.23%
Operating Profit (PBDIT)
274.63
-295.42
570.05
192.96%
Interest
10.76
48.43
-37.67
-77.78%
Exceptional Items
0.00
-1,972.16
1,972.16
100.00%
Gross Profit (PBDT)
545.08
995.62
-450.54
-45.25%
Depreciation
83.52
193.04
-109.52
-56.73%
Profit Before Tax
180.35
-2,509.06
2,689.41
107.19%
Tax
0.00
-354.05
354.05
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
180.35
-1,437.61
1,617.96
112.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
180.35
-1,437.61
1,617.96
112.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-717.40
717.40
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
180.35
-2,155.01
2,335.36
108.37%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,949.51
4,010.69
-2,061.18
-51.39%
Earnings per share (EPS)
0.18
-1.19
1.37
115.13%
Diluted Earnings per share
0.18
-1.19
1.37
115.13%
Operating Profit Margin (Excl OI)
15.78%
-41.08%
0.00
56.86%
Gross Profit Margin
38.02%
-176.51%
0.00
214.53%
PAT Margin
25.99%
-109.56%
0.00
135.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 69.40 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 187.13% vs 24.59% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 18.04 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 177.52% vs 38.57% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.30 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 168.71% vs 35.96% in Dec 2023
Annual - Interest
Interest 1.08 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -20.00% vs -18.18% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.78%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
